Canopy Growth Corporation (CGC)
NASDAQ: CGC · Real-Time Price · USD
1.050
-0.030 (-2.78%)
Aug 6, 2025, 4:00 PM - Market closed
New Relic Market Cap
Canopy Growth has a market cap or net worth of $214.97 million as of August 6, 2025. Its market cap has decreased by -66.22% in one year.
Market Cap
214.97M
Enterprise Value
372.72M
1-Year Change
-66.22%
Ranking
Category
Stock Price
$1.05
Market Cap Chart
Since May 24, 2018, Canopy Growth's market cap has decreased from $5.67B to $214.97M, a decrease of -96.21%. That is a compound annual growth rate of -36.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2025 | 194.50M | -32.63% |
| Dec 31, 2024 | 288.70M | -31.86% |
| Dec 29, 2023 | 423.70M | -62.25% |
| Dec 30, 2022 | 1.12B | -67.34% |
| Dec 31, 2021 | 3.44B | -62.54% |
| Dec 31, 2020 | 9.17B | 26.27% |
| Dec 31, 2019 | 7.26B | 34.51% |
| Dec 31, 2018 | 5.40B | -4.72% |
| May 24, 2018 | 5.67B | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 670.11B |
| Johnson & Johnson | 413.10B |
| AbbVie | 345.70B |
| AstraZeneca | 231.42B |
| Abbott Laboratories | 229.17B |
| Novartis AG | 228.98B |
| UnitedHealth Group | 223.06B |
| Novo Nordisk | 210.71B |